Medicare Group Q.P.S.C. (QSE:MCGS)
Qatar · Delayed Price · Currency is QAR | Market Cap | 1.51B +23.1% |
| Revenue (ttm) | 502.60M -4.0% |
| Net Income | 76.01M +26.6% |
| EPS | 0.27 +26.6% |
| Shares Out | 281.44M |
| PE Ratio | 19.88 |
| Forward PE | 8.80 |
| Dividend | 0.22 (4.10%) |
| Ex-Dividend Date | Apr 1, 2026 |
| Volume | 430,437 |
| Average Volume | 847,520 |
| Open | 5.28 |
| Previous Close | 5.28 |
| Day's Range | 5.26 - 5.38 |
| 52-Week Range | 4.22 - 7.21 |
| Beta | 0.23 |
| RSI | 38.81 |
| Earnings Date | Feb 23, 2026 |
About Medicare Group Q.P.S.C.
Medicare Group Q.P.S.C. operates hospital and promotes medical services in Qatar. The company provides medical services through hospitals and engages in operating clinics. It also offers medical and therapeutic care services. The company was formerly known as Al Ahli Specialized Hospital Company Q.S.C. The company was founded in 1995 and is based in Doha, Qatar. [Read more]
Financial Performance
In 2025, Medicare Group Q.P.S.C.'s revenue was 502.60 million, a decrease of -3.99% compared to the previous year's 523.49 million. Earnings were 76.01 million, an increase of 26.57%.
Financial StatementsNews
Congress Quietly Changes Medicare Coverage Rules Affecting Millions
Medicare provides coverage for millions of seniors. A recent rule change could affect those with benefits.
Medicare Is Making a Major Change to Expand Coverage as Early as April
The program may soon provide broader coverage to improve retirees' health.
Medicare Won't Pay for These Common Healthcare Costs in Retirement. Here's How to Get Them Covered
It's important to understand what Medicare does and doesn't cover.
New Medicare Rule Has Advocates Concerned About Limits on Care
Medicare is imposing strict new restrictions that advocates are worried could affect retirees.
Medicare Paid $12.3 Billion for These Services in 2024 & Now It's Limiting Coverage
Many retirees depend on Medicare services that are now harder to qualify for.
Medicare will run out of money 12 years earlier than expected
The Congressional Budget Office warns America’s public retirement programs are deteriorating at a shocking rate.
Ozempic Price War - Novo Nordisk Slashes Prices By 50%
Novo Nordisk A/S (NYSE: NVO) shares are down during Wednesday’s premarket session. The down move comes as the company announced plans to cut the list prices of its GLP-1 drugs by up to 50% in the U.S...
The vital measure of senior health that Medicare ignores
Nursing facilities receive high marks for preventing falls even as patient mobility declines.
RFK Jr. shakes up leadership team
The health secretary said Medicare Director Chris Klomp will now oversee all department operations.
Oz alleges Maine 'looks a lot like Minnesota' regarding entitlement fraud
The Trump administration’s top Medicare official has suggested that alleged fraud in Maine’s social services programs may be on par with the welfare fraud scandal in Minnesota. Centers for Medicare an...
Novo Nordisk is being more cautious on Medicare, says Mizuho's Holz
CNBC’s “Fast Money” team discusses why GLP-1 drugmaker stocks are diverging with Jared Holz of Mizuho.
Eli Lilly CEO Says Medicare Coverage Of Obesity Drugs Could Be Game-Changer For Its Weight-Loss Pill
Medicare's upcoming coverage of obesity treatments could dramatically expand access to Eli Lilly's (NYSE: LLY) experimental weight-loss pill, orforglipron, CEO Dave Ricks said Friday. Medicare Covera...
Los Angeles hospice fraud reaches billions as Medicare providers scam federal system with fake companies
Hospice fraud explodes in Los Angeles with providers allegedly scamming $3.5 billion from Medicare through ghost patients and fraudulent sham companies.
California governor accuses Dr Oz of discrimination over fraud claims in LA’s Armenian community
Medicare head alleged that members of city’s Armenian community engaged in large-scale healthcare fraud US politics live – latest updates A new front in the battle between the California governor, Gav...
Stock Of The Day: Where Is The Bottom For CVS?
CVS Health Corporation (NYSE: CVS) is flat on Wednesday. The shares dropped by almost 15% yesterday after it was reported that Medicare was proposing rates that are well below expectations . • What’s...
Medicare is about to start negotiating the prices of some medications administered by doctors
The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.
Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
The U.S. Centers for Medicare & Medicaid Services (CMS) announced the selection of 15 high-cost prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program, marking the first...
Trump Administration Proposes Keeping Steady the Rates Medicare Pays Insurers
Medicare Advantage Will Officially Exclude These Items in 2026
There are new restrictions coming to Medicare in 2026.
New Medicare Advantage Rule Forbids Coverage of Procedures Used by Over 4 Million Seniors
Medicare says covering these procedures is totally off the table.
Former White House advisor on the real reason your health care costs are going up: Medicare’s doctor pay gap
For years, Medicare has paid more for services and procedures provided in a hospital than in a physician practice.
Medicare drug price negotiations may save some retirees more than 50% in 2026, AARP finds
The first 10 drugs subject to Medicare price negotiations go into effect on Jan. 1. Part D enrollees may see those drug costs drop by about half, AARP finds.
Pennsylvania nursing home blast: Facility rated ‘much below average’ in health inspections
US News: The Silver Lake Nursing Home, the site of a devastating explosion on Tuesday, had an overall rating of one star on Medicare’s federal Care Compare sys.
Medicare enrollees to pay 50 percent less for some drugs next year: Study
Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP. The study, published Thursday, found that the out-of-pocket cost of...
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations